Brief: FDA Accepts Ascelia Pharma Type A Meeting Request
17/08/2026 14:26
BRIEF-FDA Accepts Ascelia Pharma Type A Meeting Request Aug 17 (Reuters) - Ascelia Pharma AB ACELP.ST:
U.S. FOOD AND DRUG ADMINISTRATION (FDA) ACCEPTS TYPE A MEETING REQUEST TO REVIEW RESPONSE TO ORVIGLANCE NDA CRL
FDA SCHEDULES TYPE A MEETING FOR ORVIGLANCE NDA ON SEPTEMBER 9, 2026
Source text: ID:nMFN9QSlnT
Further company coverage: ACELP.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))